These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9221462)

  • 21. [Mucosa protective therapy with long-term nonsteroidal antirheumatic drugs].
    Cozzarini W; Rath J; Bauer A; Györög I; Györög M; Prenner M; Trianto T; Maderbacher H; Höller E; Grusch B; Sebesta C
    Wien Med Wochenschr; 2003; 153(13-14):295-303. PubMed ID: 12924104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Peptic ulcer, Helicobacter pylori].
    Bauerfeind P; Wirth HP
    Ther Umsch; 1997 Nov; 54(11):624-8. PubMed ID: 9454363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Peptic ulcer: facts and questions -- 2010].
    Hagymási K; Tulassay Z
    Orv Hetil; 2010 Jun; 151(26):1054-61. PubMed ID: 20558352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathogen eradication prevents gastrointestinal complications].
    MMW Fortschr Med; 2007 Oct; 149(43):58-9. PubMed ID: 17992910
    [No Abstract]   [Full Text] [Related]  

  • 25. Underutilization of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugs.
    Smalley W; Stein CM; Arbogast PG; Eisen G; Ray WA; Griffin M
    Arthritis Rheum; 2002 Aug; 46(8):2195-200. PubMed ID: 12209525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chemotherapy and NSAIDs in neoplastic disease. Role of anti-secretory preventive therapy].
    Annibale B; Panzuto F
    Recenti Prog Med; 2003 Nov; 94(11):473-7. PubMed ID: 14679914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helicobacter pylori and non-malignant diseases.
    Rokkas T; Simsek I; Ladas S
    Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
    Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
    Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease.
    Joshua FF; Oakley SP; Major GA
    Intern Med J; 2004 Apr; 34(4):153-61. PubMed ID: 15086694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inadequate prevention of NSAID-induced gastrointestinal events.
    Herings RM; Goettsch WG
    Ann Pharmacother; 2004 May; 38(5):760-3. PubMed ID: 15031416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevention and therapy of non-steroidal antirheumatic drug-induced ulcers: an update].
    Thumshirn M; Fried M
    Dtsch Med Wochenschr; 2000 Aug; 125(33):975-8. PubMed ID: 10994406
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of the effects of diclofenac or other non-steroidal anti-inflammatory drugs (NSAIDs) and diclofenac or other NSAIDs in combination with proton pump inhibitors (PPI) on hospitalisation due to peptic ulcer disease.
    Höer A; Gothe H; Schiffhorst G; Sterzel A; Grass U; Häussler B
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):854-8. PubMed ID: 17323403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of NSAID-related gastroduodenal mucosal injury.
    Aalykke C; Lauritsen K
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):705-22. PubMed ID: 11566036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-steroidal anti-inflammatory drugs: who should receive prophylaxis?
    Hawkey CJ
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 2():59-64. PubMed ID: 15335414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicobacter pylori and nonsteroidal anti-inflammatory drug interactions in bleeding ulcers.
    Radaelli F; Minoli G
    Gastrointest Endosc; 2002 Oct; 56(4):604-6; discussion 606-7. PubMed ID: 12375565
    [No Abstract]   [Full Text] [Related]  

  • 38. [Guideline 'NSAID use and the prevention of gastric damage'].
    Moens HJ; van Croonenborg JJ; Al MJ; van den Bemt PM; Lourens J; Numans ME;
    Ned Tijdschr Geneeskd; 2004 Mar; 148(13):604-8. PubMed ID: 15083624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori eradication in long-term users of non-steroidal anti-inflammatory drugs.
    Chan FK; Sung JJ
    Lancet; 1998 Dec 19-26; 352(9145):2016; author reply 2017. PubMed ID: 9872268
    [No Abstract]   [Full Text] [Related]  

  • 40. [Consequences of Helicobacter pylori infection on the incidence and treatment of gastro-duodenal ulcers in patients taking non-steroidal anti-inflammatory agents].
    Lamarque D
    Gastroenterol Clin Biol; 1998 Dec; 22(12):1122-4. PubMed ID: 10051998
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.